Rudolf Berger

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study
    Rudolf Berger
    Department of Cardiology, General Hospital of St Pölten, St Polten, Austria
    Eur Heart J 30:2109-16. 2009
  2. doi N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
    Rudolf Berger
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 55:645-53. 2010
  3. doi Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure
    Kathrin Rychli
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Heart 97:1158-63. 2011
  4. ncbi Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure
    Rudolf Berger
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
    Eur J Heart Fail 9:202-8. 2007
  5. ncbi A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
    Bernhard Richter
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Int J Cardiol 168:1251-7. 2013
  6. doi Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 53:1783-90. 2009
  7. doi Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure
    Kathrin Rychli
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Chest 138:656-64. 2010
  8. doi Fractalkine is an independent predictor of mortality in patients with advanced heart failure
    Bernhard Richter
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Thromb Haemost 108:1220-7. 2012
  9. doi Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    Stephanie Neuhold
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 52:266-72. 2008
  10. ncbi Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period
    Rudolf Berger
    Department of Cardiology, Ludwig Boltzman Institute of Experimental Endocrinology, University of Vienna, Vienna, Austria
    J Heart Lung Transplant 22:1037-45. 2003

Collaborators

Detail Information

Publications37

  1. doi Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study
    Rudolf Berger
    Department of Cardiology, General Hospital of St Pölten, St Polten, Austria
    Eur Heart J 30:2109-16. 2009
    ..We evaluated whether the prognostic value of NT-proBNP was influenced by CRT and the effects of CRT stratified according to NT-proBNP...
  2. doi N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
    Rudolf Berger
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 55:645-53. 2010
    ....
  3. doi Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure
    Kathrin Rychli
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Heart 97:1158-63. 2011
    ..To assess the prognostic value of the mitogenic, antiapoptotic, angiogenic and antifibrotic hepatocyte growth factor (HGF) in heart failure (HF)...
  4. ncbi Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure
    Rudolf Berger
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
    Eur J Heart Fail 9:202-8. 2007
    ..In advanced chronic heart failure (CHF) 20% of patients do not tolerate beta-blockers and 50% do not reach target doses...
  5. ncbi A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
    Bernhard Richter
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Int J Cardiol 168:1251-7. 2013
    ..Accurate risk prediction is important for an adequate management of heart failure (HF) patients. We assessed the incremental prognostic ability of a multi-biomarker approach in advanced HF...
  6. doi Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 53:1783-90. 2009
    ....
  7. doi Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure
    Kathrin Rychli
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Chest 138:656-64. 2010
    ..We investigated the role of pigment epithelium-derived factor (PEDF), a recently discovered antiangiogenic factor with additional proapoptotic effects, in patients with advanced HF...
  8. doi Fractalkine is an independent predictor of mortality in patients with advanced heart failure
    Bernhard Richter
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Thromb Haemost 108:1220-7. 2012
    ..Fractalkine improves risk prediction beyond NT-proBNP and might therefore help to identify high risk patients who need special care. Our data indicate the implication of immune modulation in HF pathology...
  9. doi Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    Stephanie Neuhold
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 52:266-72. 2008
    ....
  10. ncbi Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period
    Rudolf Berger
    Department of Cardiology, Ludwig Boltzman Institute of Experimental Endocrinology, University of Vienna, Vienna, Austria
    J Heart Lung Transplant 22:1037-45. 2003
    ..Because stimuli for forming these neurohormones differ, this study investigates whether their prognostic power depends on clinical stage and on length of the observation period...
  11. ncbi Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression
    Marianne Gwechenberger
    Department of Cardiology, University of Vienna, Vienna, Austria
    J Heart Lung Transplant 24:2190-5. 2005
    ..We hypothesized that levels of circulating sgp130 and cardiac peptides provide independent prediction of worsening pump failure in the long term...
  12. ncbi N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients
    Brigitte Meyer
    Department of Cardiology, Clinical Institute for Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria
    Crit Care Med 35:2268-73. 2007
    ..The present study tests the prognostic information of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in an unselected cohort of critically ill patients...
  13. doi B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Card Fail 15:233-40. 2009
    ..However, which patients really benefit from such an intervention remains unclear. We investigated if B-type natriuretic peptide (BNP), a strong prognostic marker in chronic heart failure, can predict benefit from HBNC...
  14. doi NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
    Martin Huelsmann
    Department of Cardiology, Medical University Vienna, Vienna, Austria
    Eur Heart J 29:2259-64. 2008
    ..This study evaluated the predictive value of NT-proBNP for patients with diabetes mellitus and compared the prognostic aptitude of this neurohumoral marker to traditional markers of cardiovascular events...
  15. ncbi Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failure
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Austria
    Eur J Heart Fail 7:1156-63. 2005
    ..Both levosimendan and prostaglandin E1 (PGE1) have beneficial effects on hemodynamic parameters and outcome compared to dobutamine in decompensated chronic heart failure (CHF)...
  16. ncbi Dynamics of inflammation parameters prior to tachyarrhythmias in critically ill patients
    Maria Koreny
    Department of Emergency Medicine, Vienna University Hospital, Vienna, Austria
    Wien Klin Wochenschr 117:342-7. 2005
    ..We evaluated the course of inflammation parameters over 48 hours before the occurrence of tachyarrhythmias...
  17. doi Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure
    Bernhard Richter
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Atherosclerosis 213:545-8. 2010
    ..To assess the prognostic value of the pro-apoptotic, but also cell growth-inducing molecule soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) in heart failure (HF)...
  18. doi Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients
    Christopher Adlbrecht
    Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur J Heart Fail 11:361-6. 2009
    ..The aim of the present study was to assess the prognostic value of midregional-pro-adrenomedullin (MR-proADM) and C-terminal-pro-endothelin-1 (CT-proET-1) in outpatients with CHF...
  19. ncbi Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide
    Brigitte Meyer
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    J Am Coll Cardiol 46:1011-8. 2005
    ..The aim of this study was to assess the predictive potency of impaired endothelium-dependent flow-mediated vasodilation (FMD) in patients with chronic heart failure (CHF)...
  20. ncbi Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure Survey
    Martin Hülsmann
    Department of Cardiology, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur J Heart Fail 7:657-61. 2005
    ..To evaluate the prescription rate of neurohumoral drugs in chronic heart failure patients and the factors influencing prescription rates. Outcomes and their predisposing factors were also investigated...
  21. ncbi Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide
    Martin Hülsmann
    Department of Cardiology, University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur J Heart Fail 7:552-6. 2005
    ..Attention was focused on patients with normal values and the implications of these on survival...
  22. ncbi Muscle strength as a predictor of long-term survival in severe congestive heart failure
    Martin Hülsmann
    Department of Cardiology, University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Eur J Heart Fail 6:101-7. 2004
    ..The objective of the study was to test the relationship between isolated muscle strength and outcome, and its significance in the context of other exercise variables...
  23. doi Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care
    Christopher Adlbrecht
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Eur J Clin Invest 41:315-22. 2011
    ..As re-hospitalization is the main contributing economic factor in heart failure expenditures, we hypothesized that this programme might be able to reduce costs and could be conducted cost effectively compared to UC...
  24. doi Prognostic value of apoptosis markers in advanced heart failure patients
    Alexander Niessner
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Eur Heart J 30:789-96. 2009
    ..The purpose of this study was to assess whether the pro-apoptotic molecules apoptosis-stimulating fragment (FAS, CD95/APO-1) and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) predict event-free survival of HF patients...
  25. doi Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Eur J Heart Fail 10:404-11. 2008
    ..We evaluated the prognostic value of sequential NT-proBNP values in ambulatory heart failure patients after discharge, investigating whether the current value or the recent percent change is more important...
  26. ncbi Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure
    Jutta Bergler-Klein
    Department of Cardiology University of Vienna, Vienna, Austria
    J Heart Lung Transplant 23:20-7. 2004
    ..Effects on neurohormones and hemodynamics were evaluated...
  27. ncbi Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure
    Marianne Gwechenberger
    Department of Cardiology, University of Vienna, Vienna, Austria
    J Heart Lung Transplant 23:839-44. 2004
    ..However, direct comparisons between them are rare and the best predictor for worsening of heart failure remains to be elucidated. The aim of the study was to identify independent predictors for worsening of heart failure...
  28. ncbi Heart transplantation provides long-term survival benefit in stable patients experiencing heart failure without reverse left ventricular remodeling
    Brigitte Meyer
    Department of Cardiology, Medical University of Vienna, Vienna, Austria
    Transplantation 82:1463-71. 2006
    ..This study compared the outcome of stable patients with CHF with patients after heart transplantation in the long-term...
  29. doi Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume
    Christopher Adlbrecht
    Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur Heart J 29:2343-50. 2008
    ..Our data support an additional independent, but minor influence of iron deficiency on haemoglobin concentrations in CHF patients...
  30. ncbi B-type natriuretic peptide predicts sudden death in patients with chronic heart failure
    Rudolf Berger
    Department of Cardiology, Ludwig Boltzman Institute of Experimental Endocrinology and Ludwig Boltzman Institute of Cardiovascular Research, University of Vienna, Austria
    Circulation 105:2392-7. 2002
    ..B-type natriuretic peptide (BNP) has prognostic significance in CHF, and the stimuli for its production cause electrophysiological abnormalities. This study tests BNP levels as a predictor of sudden death...
  31. doi Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure
    Deddo Moertl
    Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
    Thromb Haemost 106:457-65. 2011
    ..2 was decreased by 4 g/day n3-PUFA (P = 0.03). In patients with severe non-ischaemic CHF, treatment with n3-PUFA leads to a dose-dependent decrease of platelet activation and TF. Higher dosage exhibits also anti-inflammatory effects...
  32. doi Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study
    Deddo Moertl
    Department of Cardiology, Medical University of Vienna, Austria
    Am Heart J 161:915.e1-9. 2011
    ..However, a dose-efficacy relationship was postulated for the beneficial effects of n3-PUFA before. Therefore, we evaluated dose-dependent effects of n3-PUFA in patients with severe CHF...
  33. ncbi Beneficial effects of chronic low-frequency stimulation of thigh muscles in patients with advanced chronic heart failure
    Martin J Nuhr
    Department of Physical Medicine and Rehabilitation, General Hospital Vienna, University of Vienna, Vienna, Austria
    Eur Heart J 25:136-43. 2004
    ..This study investigates the possibility of counteracting these changes by chronic low-frequency electrical stimulation (CLFS) of left and right thigh muscles...
  34. ncbi Endothelin receptor antagonists in cardiology clinical trials
    Thomas Neunteufl
    Department of Cardiology, University of Vienna Medical School, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    Expert Opin Investig Drugs 11:431-43. 2002
    ..This article reviews recently completed and ongoing clinical trials examining the effects of ET receptor antagonists in patients with heart failure, CAD, arterial hypertension and pulmonary hypertension...
  35. doi Needle image plates compared to conventional CR in chest radiography: is dose reduction possible?
    Vanessa Berger-Kulemann
    Department of Radiology, Medical University of Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Eur J Radiol 81:4156-60. 2012
    ..To compare image quality of standard-dose computed radiography and dose reduced needle-technology CR for supine CXR in a clinical setting...
  36. ncbi Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU
    Georg Delle Karth
    Department of Cardiology, University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Intensive Care Med 29:963-8. 2003
    ..To assess the diurnal distribution of ventricular tachycardia (VT) and atrial fibrillation (AF) in critically ill patients...
  37. ncbi Prognostic impact of workload in patients with congestive heart failure
    Martin Huelsmann
    Department of Cardiology, University of Vienna, Vienna, Austria
    Am Heart J 143:308-12. 2002
    ..These parameters were not yet compared in a multivariate analysis...